AliquantumRx Inc. Announces New Research Collaboration and Development Agreement with Johns Hopkins University to Advance Cethromycin HCl for Liver-Stage Malaria
AliquantumRx Inc. announced today the execution of a new collaborative research agreement with The Johns Hopkins University to advance the development of cethromycin hydrochloride (Cethromycin HCl) for the treatment and prevention of liver-stage malaria. Under the agreement, investigators from Johns Hopkins and AliquantumRx will collaborate on translational and preclinical research activities supporting the continued development of Cethromycin HCl, including […]